Background: Successful outcome of obstetric well-being is to assess by obtaining healthy mother and child in modern obstetrics. Assessment of fetal well-being is important in timely diagnosis of fetal compromise and management. Amniotic fluid serves a major role in the development of the fetus. Aims and Objectives: The present study aims to evaluate the oligohydramnios pregnancies admitted in IPD of G & O, Bankura Sammilani Medical College & Hospital in terms of intrauterine growth restriction (IUGR) and perinatal outcomes. Materials and Methods: The study was conducted at Bankura Sammilani Medical College and Hospital, West Bengal, in terms of IUGR and perinatal outcomes from April 2020 to September 2021 among 80 antenatal mothers diagnosed to have oligohydramnios and subsequently admitted in-patients-department. Thorough history taking and clinical examination was done. Template was generated in MS Excel sheet and analysis was done on SPSS software. Results: Among 80 antenatal mothers diagnosed with oligohydramnios, the mean age of patients was 22.0750±4.1484. 21 (26.25%) patients had NICU admission and 56 (70.0%) patients had IUGR. In the study, 1 (1.25%) patient was perinatal death and 79 (98.75%) patients survived. In without IUGR, the mean birth weight (mean±SD) of patients was 2.7483±0.2222. In without IUGR, 1 (4.2%) patient had NICU admission. In with IUGR, 20 (35.7%) patients had NICU admission. Conclusion: Ultrasonography plays a major role in early diagnosis of IUGR. IUGR was associated with cesarean section for fetal distress, and NICU admission among oligohydramnios can be predicted using umbilical artery Doppler velocimetry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.